nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A nonfucosylated human antibody to CD19 with potent B-cell depletive activity for therapy of B-cell malignancies
|
Cardarelli, Pina M. |
|
2009 |
59 |
2 |
p. 257-265 |
artikel |
2 |
Antibody to CCDC104 is associated with a paraneoplastic antibody to CDR2 (anti-Yo)
|
Totland, Cecilie |
|
2009 |
59 |
2 |
p. 231-237 |
artikel |
3 |
A phase II trial of intraperitoneal interleukin-2 in patients with platinum-resistant or platinum-refractory ovarian cancer
|
Vlad, Anda M. |
|
2009 |
59 |
2 |
p. 293-301 |
artikel |
4 |
Assessment of the pre-clinical immunogenicity of a new VEGF receptor Fc-fusion protein FP3 with ELISA and BIACORE
|
Wang, Hui |
|
2009 |
59 |
2 |
p. 239-246 |
artikel |
5 |
Autophagy facilitates major histocompatibility complex class I expression induced by IFN-γ in B16 melanoma cells
|
Li, Bo |
|
2009 |
59 |
2 |
p. 313-321 |
artikel |
6 |
Dynamic monitoring the TCR CDR3 spectratypes in patients with metastatic CRC treated with a combination of bevacizumab, irinotecan, fluorouracil, and leucovorin
|
Luo, Wei |
|
2009 |
59 |
2 |
p. 247-256 |
artikel |
7 |
Erratum to: Amyloid precursor-like protein 2 association with HLA class I molecules
|
Tuli, Amit |
|
2009 |
59 |
2 |
p. 339 |
artikel |
8 |
Immune impairment in patients with terminal cancers: influence of cancer treatments and cytomegalovirus infection
|
Chen, I-Hsuan |
|
2009 |
59 |
2 |
p. 323-334 |
artikel |
9 |
Impact of Cytomegalovirus infection on immune signatures in cancer patients
|
Derhovanessian, Evelyna |
|
2009 |
59 |
2 |
p. 335-336 |
artikel |
10 |
Loci controlling lymphocyte production of interferon γ after alloantigen stimulation in vitro and their co-localization with genes controlling lymphocyte infiltration of tumors and tumor susceptibility
|
Lipoldová, Marie |
|
2009 |
59 |
2 |
p. 203-213 |
artikel |
11 |
Multimer technologies for detection and adoptive transfer of antigen-specific T cells
|
Casalegno-Garduño, Rosaely |
|
2009 |
59 |
2 |
p. 195-202 |
artikel |
12 |
Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?
|
Bouwhuis, Marna G. |
|
2009 |
59 |
2 |
p. 303-312 |
artikel |
13 |
Response to Dr Derhovanessian “Impact of cytomegalovirus infection on immune signatures in cancer patients”
|
Lu, Yen-Ta |
|
2009 |
59 |
2 |
p. 337 |
artikel |
14 |
Survivin as an immunotherapeutic target for adult and pediatric malignant brain tumors
|
Liu, Rebecca |
|
2009 |
59 |
2 |
p. 183-193 |
artikel |
15 |
Systemic dysregulation of CEACAM1 in melanoma patients
|
Markel, Gal |
|
2009 |
59 |
2 |
p. 215-230 |
artikel |
16 |
The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy
|
Wu, Xia |
|
2009 |
59 |
2 |
p. 279-291 |
artikel |
17 |
Tumors induce the formation of suppressor endothelial cells in vivo
|
Mulligan, Jennifer Konopa |
|
2009 |
59 |
2 |
p. 267-277 |
artikel |